Boehringer Ingelheim’s Spevigo (spesolimab) has been recommended by the National Institute for Health and Care Excellence ...

NORTHAMPTON, MA / ACCESS Newswire / June 16, 2025 / In remote communities in Argentina, access to quality healthcare is a ...

NORTHAMPTON, MA / ACCESS Newswire / June 19, 2025 / Every nine minutes, rabies claims a life. Each year, this deadly virus steals nearly 60,000 lives, despite being entirely preventable through ...

TOKYO -- German drugmaker Boehringer Ingelheim plans to invest a total of 300 million euros ($346 million) in its plant in Japan from 2023 to 2028 as it moves to make the facility a production base ...

The study, supported by Boehringer Ingelheim, included 4,000 patients from Geisinger with diabetes and/or hypertension, two prominent risk factors for CKD. Patients in the pilot group received ...

A large, multicountry European study finds that adults with type 2 diabetes who start empagliflozin experience no increased ...

A novel canine-specific detection algorithm is designed to improve early identification of heart disease and expand access to ...

Boehringer Ingelheim launches innovative poultry vaccine in India, offering single-dose protection against major diseases, ...

The agreement will facilitate access to Boehringer Ingelheim’s OpnME platform. The Department of Health – Abu Dhabi has ...